Literature DB >> 24418410

Future directions in Alzheimer's disease from risk factors to prevention.

Bushra Imtiaz1, Anna-Maija Tolppanen2, Miia Kivipelto3, Hilkka Soininen4.   

Abstract

The increase in life expectancy has resulted in a high occurrence of dementia and Alzheimer's disease (AD). Research on AD has undergone a paradigm shift from viewing it as a disease of old age to taking a life course perspective. Several vascular, lifestyle, psychological and genetic risk factors influencing this latent period have been recognized and they may act both independently and by potentiating each other. These risk factors have consequently been used to derive risk scores for predicting the likelihood of dementia. Despite population differences, age, low education and vascular risk factors were identified as key factors in all scoring systems. Risk scores can help to identify high-risk individuals who might benefit from different interventions. The European Dementia Prevention Initiative (EDPI), an international collaboration, encourages data sharing between different randomized controlled trials. At the moment, it includes three large ongoing European trials: Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER), Prevention of Dementia by Intensive Vascular Care (preDIVA), and Multidomain Alzheimer Prevention study (MAPT). Recently EDPI has developed a "Healthy Aging through Internet Counseling in Elderly" (HATICE) program, which intends to manage modifiable risk factors in an aged population through an easily accessible Internet platform. Thus, the focus of dementia research has shifted from identification of potential risk factors to using this information for developing interventions to prevent or delay the onset of dementia as well as identifying special high-risk populations who could be targeted in intervention trials.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Dementia; Prevention; Randomized controlled trials; Risk scores

Mesh:

Year:  2014        PMID: 24418410     DOI: 10.1016/j.bcp.2014.01.003

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  74 in total

1.  Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.

Authors:  H K Lückhoff; M Kidd; S J van Rensburg; D P van Velden; M J Kotze
Journal:  Metab Brain Dis       Date:  2016-02       Impact factor: 3.584

2.  Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference.

Authors:  John E Morley; John C Morris; Marla Berg-Weger; Soo Borson; Brian D Carpenter; Natalia Del Campo; Bruno Dubois; Keith Fargo; L Jaime Fitten; Joseph H Flaherty; Mary Ganguli; George T Grossberg; Theodore K Malmstrom; Ronald D Petersen; Carroll Rodriguez; Andrew J Saykin; Philip Scheltens; Eric G Tangalos; Joe Verghese; Gordon Wilcock; Bengt Winblad; Jean Woo; Bruno Vellas
Journal:  J Am Med Dir Assoc       Date:  2015-09-01       Impact factor: 4.669

3.  Multimorbidity and Risk of Mild Cognitive Impairment.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Ruth H Cha; Walter K Kremers; Jennifer L St Sauver; Michelle M Mielke; Yonas E Geda; Mary M Machulda; David S Knopman; Ronald C Petersen; Rosebud O Roberts
Journal:  J Am Geriatr Soc       Date:  2015-08-27       Impact factor: 5.562

4.  Multimorbidity and neuroimaging biomarkers among cognitively normal persons.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Michelle M Mielke; Yonas E Geda; Walter K Kremers; Rabe E Alhurani; Mary M Machulda; David S Knopman; Ronald C Petersen; Val J Lowe; Clifford R Jack; Rosebud O Roberts
Journal:  Neurology       Date:  2016-04-13       Impact factor: 9.910

5.  Voluntary exercise promotes beneficial anti-aging mechanisms in SAMP8 female brain.

Authors:  Sergi Bayod; Carolina Guzmán-Brambila; Sandra Sanchez-Roige; Jaume F Lalanza; Perla Kaliman; Daniel Ortuño-Sahagun; Rosa M Escorihuela; Mercè Pallàs
Journal:  J Mol Neurosci       Date:  2014-07-16       Impact factor: 3.444

6.  Dairy, soy, and calcium consumption and risk of cognitive impairment: the Singapore Chinese Health Study.

Authors:  Mohammad Talaei; Lei Feng; Jian-Min Yuan; An Pan; Woon-Puay Koh
Journal:  Eur J Nutr       Date:  2019-06-03       Impact factor: 5.614

7.  Meditation and Music Improve Memory and Cognitive Function in Adults with Subjective Cognitive Decline: A Pilot Randomized Controlled Trial.

Authors:  Kim E Innes; Terry Kit Selfe; Dharma Singh Khalsa; Sahiti Kandati
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 8.  Energy metabolism and inflammation in brain aging and Alzheimer's disease.

Authors:  Fei Yin; Harsh Sancheti; Ishan Patil; Enrique Cadenas
Journal:  Free Radic Biol Med       Date:  2016-05-03       Impact factor: 7.376

Review 9.  Non-Pharmacologic Interventions for Older Adults with Subjective Cognitive Decline: Systematic Review, Meta-Analysis, and Preliminary Recommendations.

Authors:  Colette M Smart; Justin E Karr; Corson N Areshenkoff; Laura A Rabin; Carol Hudon; Nicola Gates; Jordan I Ali; Eider M Arenaza-Urquijo; Rachel F Buckley; Gael Chetelat; Harald Hampel; Frank Jessen; Natalie L Marchant; Sietske A M Sikkes; Andrea Tales; Wiesje M van der Flier; Linda Wesselman
Journal:  Neuropsychol Rev       Date:  2017-03-07       Impact factor: 7.444

10.  Early Manifestations of Brain Aging in Mice Due to Low Dietary Folate and Mild MTHFR Deficiency.

Authors:  Renata H Bahous; Marta Cosín-Tomás; Liyuan Deng; Daniel Leclerc; Olga Malysheva; Ming-Kai Ho; Mercè Pallàs; Perla Kaliman; Barry J Bedell; Marie A Caudill; Rima Rozen
Journal:  Mol Neurobiol       Date:  2018-10-04       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.